The development of the Centre for Tropical and Infectious Diseases (CTID) – a new £23 million, 7,800 sq m, state-of-the-art research facility – was designed to put LSTM at the forefront of infectious disease research and to add to the growing importance of the North West of England in worldwide biomedical research and a key element of Liverpool’s Knowledge Quarter.
AMION carried out a ‘Green Book’ evaluation of the project for the Northwest Regional Development Agency in relation to its financial contribution to the project through Single Programme resources. The evaluation also had to comply with ERDF evaluation requirements in respect of European funding towards the project and ERDF resources. The evaluation critically examined the context and rationale for the project, delivery, costs and expenditure, benefits (including net additional benefits), value for money, and lessons learned. The evaluation concluded that the project had led to substantial benefits in terns of land and property, employment and GVA, skills, research capability and investment, and wider effects including competitiveness, image, and reputation. The results identified that the project was considered to be highly successful and a ‘flagship’ for Liverpool and the North West.
Our work in undertaking the evaluation was preceded by support to LSTM in successful case-making in obtaining NWDA funding to the project, and subsequent advice in relation to project monitoring. Subsequently, AMION has continued to provide further advice to LSTM, most recently in relation to a successful RGF approval for an associated new Centre for Maternal Health and Child Health project and a further expansion project with the benefit of ERDF support.
The CTID building is continuing to operate successfully. Development of the new Centre for Maternal and Child Health is due to commence in summer 2013, and the most recent expansion proposal is continuing to be progressed.